Medicare sets a 2.3% payment rise for inpatient psychiatric care in 2027
The final FY2027 rule lifts the federal per diem base rate to $912.40 and the electroconvulsive-therapy rate to $688.59 from 1 October, adds a standardised patient-assessment tool, and drops two quality measures.
| Group | Value ($) |
|---|---|
| FY2026 | 892.87 |
| FY2027 | 912.4 |
Medicare has finalised what it will pay for inpatient psychiatric care in the coming fiscal year. A final rule published in the Federal Register on 31 July 2026 updates the payment rates, outlier threshold and wage index for the Inpatient Psychiatric Facilities Prospective Payment System, the method Medicare uses to reimburse psychiatric hospitals and the specialised psychiatric units of acute-care and critical-access hospitals [s1]. The changes apply to discharges from 1 October 2026 through 30 September 2027 [s1].
The headline numbers
The rule sets a payment update of 2.3 percent for fiscal year 2027 [s1]. That figure is built the way Medicare's inpatient rules usually are: a projected price increase for the goods and services hospitals buy, trimmed by a productivity adjustment that Congress requires. Here, the Centers for Medicare & Medicaid Services applied "a 3.2 percent market basket increase" reduced by "a 0.9 percentage point" productivity adjustment, "for a total FY 2027 payment rate update of 2.3 percent" [s1].
Translated into the rates facilities actually bill, the federal per diem base rate — the daily building block of an IPF payment — rises from $892.87 to $912.40 [s1]. Facilities that fail to report the required quality data receive a lower rate of $894.56 [s1]. The payment for electroconvulsive therapy, billed per treatment, increases from $673.85 to $688.59, after CMS applied the 2.3 percent update and a wage-index budget-neutrality factor of 0.9989 [s1].
CMS also kept its outlier policy — the extra payments that cushion unusually costly cases — calibrated so that "outlier payments are estimated to remain at 2.0 percent of total estimated IPF payments in FY 2027" [s1]. To hold that 2.0 percent target as rates change, the agency updated the outlier fixed-dollar-loss threshold, the labour-related share of the base rate, and the wage index used to adjust payments for local labour costs [s1]. The per diem is not a flat sum: Medicare then modifies it case by case using patient- and facility-level adjustments before a facility is paid [s1]. The agency estimates the combined effect is an increase of about $60 million in payments to IPF providers, driven by the rate update [s1]. The impact is uneven across the field: CMS projects payments rising 2.2 percent in urban areas and 2.7 percent in rural areas, with the largest increase, 4.0 percent, for non-profit IPF hospitals in rural areas [s1].
Beyond the rates
The rule does more than reset dollar figures. CMS is "finalizing the implementation of a standardized IPF patient assessment instrument," referred to as the IPF-PAI, a data-collection tool mandated by section 4125(b)(1) of the Consolidated Appropriations Act [s1]. A standardised assessment is intended to capture consistent information on patients across facilities, the kind of data that underpins both payment refinement and quality measurement over time.
At the same time, the agency is "removing two measures" from the Inpatient Psychiatric Facilities Quality Reporting Program [s1]. That program ties a facility's full update to whether it submits required quality data — the reason non-reporters face the reduced $894.56 base rate [s1]. Trimming measures reduces reporting burden, though it also narrows the set of indicators the public can use to compare facilities.
Why it matters
Inpatient psychiatric facilities sit at the acute end of the mental-health system, caring for people in crisis who need hospital-level treatment. Because Medicare is a major payer for that care, the annual IPF rule effectively sets the financial baseline under which these units operate, and the update tends to track, rather than outpace, the costs facilities face [s1]. A 2.3 percent rise is a routine inflation-style adjustment, not a structural change to how psychiatric care is funded [s1].
The quieter shifts — a new standardised assessment instrument and a shorter quality-reporting list — may matter more in the long run than the per diem figure. Standardised patient data can reshape how Medicare refines payments and judges quality in future years, while changes to the measure set alter what gets tracked across the roughly 1,600 facilities the program covers [s1].
What to watch
Whether CMS uses the new IPF-PAI data to adjust the payment system in later rules; how the two dropped quality measures affect public reporting; and whether the rural and non-profit facilities that see the largest projected increases this year hold that ground in future updates [s1]. CMS proposed these changes on 7 April 2026 and finalised them after public comment [s2]. For patients and families, none of this changes eligibility or what an inpatient stay covers — it sets what Medicare pays the facility behind the scenes [s1].
Sources
- Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update — Centers for Medicare & Medicaid Services (Federal Register) , July 31, 2026
- Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update (proposed rule) — Centers for Medicare & Medicaid Services (Federal Register) , April 7, 2026
Medicare's new GLOBE model ties some Part B drug rebates to overseas prices
A mandatory CMS payment model finalised 2 October recalculates inflation rebates for certain physician-administered drugs against an international benchmark, and can cut a patient's coinsurance to 10%.
CMS proposes same-day Medicare coverage for some breakthrough devices
The RAPID pathway would issue a proposed national coverage decision the day a device clears the FDA, cutting a process that normally runs 9 to 12 months. The trade-off is evidence.
Medicare sets a 2.4% pay rise for hospitals in its 2027 inpatient rule
The final rule raises operating payment rates 2.4% and directs about $2.9 billion more to acute-care hospitals in the year from 1 October 2026. Hospital groups called the increase too low.
Medicare's harder problem isn't the negotiated price - it's getting it to the counter
CMS took comment through 18 September 2026 on draft rules for how manufacturers must deliver negotiated drug prices in 2028. The mechanism is a refund owed within 14 days, not a lower shelf price.